Methylphenidate Hydrochloride Tablet, Extended Release
Pricing Report NDC 13811-700-30

Current NADAC: $18.80479 per EA · Effective Aug 19, 2026 · Est. package price $564.14 (30 EA)
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

The current wholesale acquisition cost for Methylphenidate Hydrochloride (NDC 13811-700-30) is $18.80479 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 19, 2026.

As a a human prescription drug provided by Trigen Laboratories, Llc, this medication is distributed in a 30 TABLET, EXTENDED RELEASE in 1 BOTTLE configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$18.80479
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 19, 2026
Billable Units
30 EA
Estimated Package Price
$564.14
Data Status
As of Sep 09, 2026
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
13811-700-30
Description
30 TABLET, EXTENDED RELEASE in 1 BOTTLE
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Apr 2024, the NADAC wholesale price for (NDC ) has moved within a range of $15.57990 to $19.18828 per EA. Over this 2 years and 4 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$15.5799 - $19.1883
Market Volatility
23.16% Variance
Latest Trend
1.28%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 19, 2026 $18.80479 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 22, 2026 $18.56668 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 17, 2026 $18.41459 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 20, 2026 $18.31742 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 22, 2026 $18.19059 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 18, 2026 $18.35700 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 18, 2026 $18.86180 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 21, 2026 $19.14071 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 17, 2025 $19.18828 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 19, 2025 $18.80375 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 22, 2025 $19.15835 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 17, 2025 $19.15172 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: September 09, 2026